BCBP CEO Receives 26,942 Stock Options at $9.91 – Form 4 Filing
BCB Bancorp (BCBP) filed a Form 4 reporting a routine equity incentive granted to Chief Executive Officer and director Michael A. Shriner.
Rhea-AI Filing Summary
BCB Bancorp (BCBP) filed a Form 4 reporting a routine equity incentive granted to Chief Executive Officer and director Michael A. Shriner. On 02/24/2025 he received an option to purchase 26,942 common shares at an exercise price of $9.91, expiring 02/24/2035. The award vests 1/3 per year beginning on the first anniversary of the grant date.
No open-market purchase or sale of common stock was disclosed in Table I. After the reported transaction Shriner directly owns 33,500 common shares and 26,942 derivative securities (the new option). Ownership is shown as direct, and the filing was submitted by a single reporting person.
The transaction is an internal compensation event with no immediate cash movement or change to outstanding share count; therefore, its impact on BCB Bancorp’s capital structure and near-term financials is minimal.
Positive
- None.
Negative
- None.
Insights
TL;DR: Standard CEO option grant; limited investor impact and no cash outlay.
The filing documents an at-market option grant to incentivize the CEO. Such awards are customary and do not signal buying or selling pressure. While the option could introduce modest future dilution, 26.9k shares represent a small fraction of BCBP’s total shares outstanding, so dilution risk is negligible. There are no sales, purchases, or red flags disclosed. Overall, the event is immaterial to valuation and should be viewed as neutral from a governance and capital-allocation standpoint.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to purchase | 26,942 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Stock options vest at the rate of 1/3 per year commencing on the first anniversary of the grant date.
FAQ
What did BCBP CEO Michael Shriner report on Form 4?
When do the newly granted BCBP options vest?
Is there any common-stock sale or purchase disclosed in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.